(EN) The present invention relates to anti-CD66c antibodies which bind to CD66c expressed on an MDSC, and the use thereof, and relates to anti-CD66c antibodies which bind to an MDSC, and a pharmaceutical composition and a diagnostic composition comprising same. The anti-CD66c antibodies of the present invention target an MDSC inducing immunosuppression and thus can be utilized for treating various diseases due to same.